步行对老年男性冠状动脉疾病的影响:霍诺卢卢心脏计划
A A Hakim1, J D Curb, H Petrovitch
1Division of Biostatistics and Epidemiology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Circulation
|July 7, 1999
概括
每天步行超过1.5英里可以显著降低老年男性冠状动脉疾病的风险. 即使是适度的步行也提供了一些保护,强调了活跃生活方式对老年人的好处.
科学领域:
- 老年学是一门学科.
- 心血管健康 心血管健康
- 预防医学 预防医学
背景情况:
- 步行对老年人冠心病 (CHD) 风险的影响尚不清楚.
- 以前的研究还没有确定步行习惯与老年人群中心血管疾病发病率或死亡率之间的明确联系.
研究的目的:
- 在一组老年男性中调查步行距离与患冠心病的风险之间的关联.
主要方法:
- 霍诺卢卢心脏计划检查了2678名身体有能力的老年男性 (71-93岁) 的步行距离 (英里/天).
- 在2至4年的随访期间,追踪了冠状动脉心脏病的发病情况.
- 统计分析根据步行距离对心脏病风险进行了比较.
主要成果:
- 男人每天步行不到0.25英里的人患心血管疾病的风险是每天步行超过1.5英里的人 (5.1%对2.5%) 的两倍.
- 每天步行0.25至1.5英里的人也比最长的步行者 (4.5%对2.5%) 显著增加心脏病风险.
- 这些关联在调整年龄和其他心血管风险因素后仍然显著.
结论:
- 增加步行距离与体能较强的老年男性冠心病风险降低有关.
- 在老年人中鼓励步行可能会带来显著的心血管健康益处.
- 这些发现支持了更广泛的证据,即活跃的生活方式有利于不同年龄组的心血管健康.
相关概念视频
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


